Guangxi LiuYao Group Co Ltd
SSE:603368
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Guangxi LiuYao Group Co Ltd
Accrued Liabilities
Guangxi LiuYao Group Co Ltd
Accrued Liabilities Peer Comparison
1099
601607
600998
000963
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
G
|
Guangxi LiuYao Group Co Ltd
SSE:603368
|
Accrued Liabilities
¥117.5m
|
CAGR 3-Years
390%
|
CAGR 5-Years
126%
|
CAGR 10-Years
N/A
|
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Accrued Liabilities
¥35.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
13%
|
CAGR 10-Years
21%
|
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Accrued Liabilities
¥10.9B
|
CAGR 3-Years
139%
|
CAGR 5-Years
73%
|
CAGR 10-Years
39%
|
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Accrued Liabilities
¥991m
|
CAGR 3-Years
79%
|
CAGR 5-Years
61%
|
CAGR 10-Years
32%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Accrued Liabilities
¥386m
|
CAGR 3-Years
53%
|
CAGR 5-Years
33%
|
CAGR 10-Years
30%
|
|
|
Huadong Medicine Co Ltd
SZSE:000963
|
Accrued Liabilities
¥570m
|
CAGR 3-Years
67%
|
CAGR 5-Years
34%
|
CAGR 10-Years
28%
|
See Also
What is Guangxi LiuYao Group Co Ltd's Accrued Liabilities?
Accrued Liabilities
117.5m
CNY
Based on the financial report for Mar 31, 2024, Guangxi LiuYao Group Co Ltd's Accrued Liabilities amounts to 117.5m CNY.
What is Guangxi LiuYao Group Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
126%
Over the last year, the Accrued Liabilities growth was 894%. The average annual Accrued Liabilities growth rates for Guangxi LiuYao Group Co Ltd have been 390% over the past three years , 126% over the past five years .
You don't have any saved screeners yet
